Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease | Zendy

W. Schuyler Jones | Zendy; Iris Baumgärtner | Zendy; William R. Hiatt | Zendy; Gretchen Heizer | Zendy; Michael S. Conte | Zendy; Christopher J. White | Zendy; Jeffrey S. Berger | Zendy; Peter Held | Zendy; Brian G. Katona | Zendy; Kenneth W. Mahaffey | Zendy; Lars Norgren | Zendy; Juuso Blomster | Zendy; Marcus Millegård | Zendy; Martin Craig | Zendy; Manesh R. Patel | Zendy; F. Gerry R. Fowkes | Zendy

Open Access

Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease

Author(s) -

W. Schuyler Jones,

Iris Baumgärtner,

William R. Hiatt,

Gretchen Heizer,

Michael S. Conte,

Christopher J. White,

Jeffrey S. Berger,

Peter Held,

Brian G. Katona,

Kenneth W. Mahaffey,

Lars Norgren,

Juuso Blomster,

Marcus Millegård,

Martin Craig,

Manesh R. Patel,

F. Gerry R. Fowkes

Publication year - 2016

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.116.025880

Subject(s) - medicine , revascularization , ticagrelor , hazard ratio , myocardial infarction , cardiology , clopidogrel , clinical endpoint , stroke (engine) , surgery , coronary artery disease , randomized controlled trial , confidence interval , mechanical engineering , engineering

In patients with symptomatic peripheral artery disease with a history of limb revascularization, the optimal antithrombotic regimen for long-term management is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research